• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Prostate cancer screening: going beyond the clinical evidence.前列腺癌筛查：超越临床证据
CMAJ. 2014 Nov 4;186(16):1201-2. doi: 10.1503/cmaj.141252. Epub 2014 Oct 27.
2
Recommendations on screening for prostate cancer with the prostate-specific antigen test.关于使用前列腺特异性抗原检测进行前列腺癌筛查的建议。
CMAJ. 2014 Nov 4;186(16):1225-34. doi: 10.1503/cmaj.140703. Epub 2014 Oct 27.
3
Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?前列腺特异性抗原、前列腺癌筛查与病理学家：我们应扮演何种角色？
Arch Pathol Lab Med. 2013 Mar;137(3):308-9. doi: 10.5858/arpa.2012-0241-ED. Epub 2012 Jul 16.
4
Doing it right: how, not whether, to perform prostate-specific antigen screening.正确做法：如何进行前列腺特异性抗原筛查，而非是否进行筛查。
Eur Urol. 2015 Sep;68(3):361-2. doi: 10.1016/j.eururo.2015.02.035. Epub 2015 Mar 18.
5
Alternative prostate cancer screening strategies.前列腺癌筛查的替代策略。
Ann Intern Med. 2013 May 21;158(10):778. doi: 10.7326/0003-4819-158-10-201305210-00019.
6
Alternative prostate cancer screening strategies--in response.替代性前列腺癌筛查策略——回应
Ann Intern Med. 2013 May 21;158(10):778-9. doi: 10.7326/0003-4819-158-10-201305210-00020.
7
Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.劳伦斯·克洛茨论前列腺癌筛查引发的争议。
Oncology (Williston Park). 2016 Aug;30(8):694, 764.
8
Probability, uncertainty, and prostate cancer.概率、不确定性与前列腺癌。
Ann Intern Med. 2013 Feb 5;158(3):211-212. doi: 10.7326/0003-4819-158-3-201302050-00012.
9
Early detection of prostate cancer.前列腺癌的早期检测
Urol Clin North Am. 2014 May;41(2):xi-xii. doi: 10.1016/j.ucl.2014.03.002.
10
Should you get a prostate screening? New evidence shows screenings are down across the country.你应该进行前列腺筛查吗？新证据表明，全国范围内的筛查数量都在下降。
Harv Health Lett. 2014 Jul;39(9):6.

引用本文的文献

1
Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised learning: a pilot study.使用拉曼光谱和半监督学习预测接受 HDR 近距离治疗的前列腺癌患者的疾病进展指标：一项初步研究。
Sci Rep. 2022 Sep 6;12(1):15104. doi: 10.1038/s41598-022-19446-4.
2
Post-Treatment Adverse Health Correlates among Prostate Cancer Survivors in a Sample of Men Residing in Atlantic Canada.加拿大大西洋地区男性前列腺癌幸存者治疗后不良健康相关因素分析。
Curr Oncol. 2021 Jul 25;28(4):2812-2822. doi: 10.3390/curroncol28040246.
3
Male Oncology Research and Education program for men at high risk for prostate cancer.针对前列腺癌高危男性的男性肿瘤学研究与教育项目。
Curr Oncol. 2018 Apr;25(2):170-175. doi: 10.3747/co.25.3818. Epub 2018 Apr 30.
4
Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices.用于前列腺癌筛查的前列腺特异性抗原检测：加拿大初级保健医生观点与实践的全国性调查。
Can Urol Assoc J. 2017 Dec;11(12):396-403. doi: 10.5489/cuaj.4486. Epub 2017 Nov 1.
5
Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.能否覆水难收？影响癌症筛查决策的情感因素定性研究。
BMC Cancer. 2017 Sep 13;17(1):647. doi: 10.1186/s12885-017-3596-7.
6
Update on age-appropriate preventive measures and screening for Canadian primary care providers.加拿大初级保健提供者的适龄预防措施及筛查最新情况
Can Fam Physician. 2016 Feb;62(2):131-8.
7
Getting (Along) With the Guidelines: Reconciling Patient Autonomy and Quality Improvement Through Shared Decision Making.遵循指南：通过共同决策协调患者自主权与质量改进
Acad Med. 2016 Jul;91(7):925-9. doi: 10.1097/ACM.0000000000001101.

本文引用的文献

1
Recommendations on screening for prostate cancer with the prostate-specific antigen test.关于使用前列腺特异性抗原检测进行前列腺癌筛查的建议。
CMAJ. 2014 Nov 4;186(16):1225-34. doi: 10.1503/cmaj.140703. Epub 2014 Oct 27.
2
Decision making and prostate cancer screening.决策与前列腺癌筛查。
Urol Clin North Am. 2014 May;41(2):257-66. doi: 10.1016/j.ucl.2014.01.008. Epub 2014 Feb 28.
3
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.前列腺癌筛查是否具有成本效益？加拿大不列颠哥伦比亚省基于前列腺特异性抗原筛查的微观模拟模型。
Int J Cancer. 2014 Aug 15;135(4):939-47. doi: 10.1002/ijc.28732. Epub 2014 Feb 4.
4
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.前列腺癌筛查：美国医师学院临床指南委员会的指导声明。
Ann Intern Med. 2013 May 21;158(10):761-769. doi: 10.7326/0003-4819-158-10-201305210-00633.
5
Quality-of-life effects of prostate-specific antigen screening.前列腺特异性抗原筛查对生活质量的影响。
N Engl J Med. 2012 Aug 16;367(7):595-605. doi: 10.1056/NEJMoa1201637.
6
Healthcare costs associated with prostate cancer: estimates from a population-based study.前列腺癌相关的医疗保健费用：基于人群的研究估计。
BJU Int. 2010 Feb;105(3):338-46. doi: 10.1111/j.1464-410X.2009.08758.x. Epub 2009 Jul 7.
7
Why consider patients' preferences? A discourse analysis of clinical practice guideline developers.为何要考虑患者的偏好？对临床实践指南制定者的话语分析
Med Care. 2009 Aug;47(8):908-15. doi: 10.1097/MLR.0b013e3181a81158.
8
The next step in guideline development: incorporating patient preferences.指南制定的下一步：纳入患者偏好。
JAMA. 2008 Jul 23;300(4):436-8. doi: 10.1001/jama.300.4.436.
9
Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.前列腺癌患者及社区对治疗结果的偏好：对临床政策的影响
Med Care. 2003 Jan;41(1):153-64. doi: 10.1097/00005650-200301000-00017.
10
Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer.以患者为导向的前列腺效用量表（PORPUS）的构建：一种用于前列腺癌的多属性健康状态分类系统。
J Clin Epidemiol. 2000 Sep;53(9):920-30. doi: 10.1016/s0895-4356(00)00211-0.

Prostate cancer screening: going beyond the clinical evidence.

作者信息

Krahn Murray

机构信息

Toronto Health Economics and Technology Assessment Collaborative; Department of Medicine and Faculty of Pharmacy, University of Toronto and University Health Network, Toronto, Ont.

出版信息

CMAJ. 2014 Nov 4;186(16):1201-2. doi: 10.1503/cmaj.141252. Epub 2014 Oct 27.

DOI:10.1503/cmaj.141252
PMID:25349002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4216248/
Abstract
摘要